Louise Roy

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

A non-(1–84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

Raymond Lepage, Louise Roy, Jean‐Hugues Brossard et al. · Clinical Chemistry · 1998 · 364 citations

Nichols Assay, Immunology, Intact Parathyroid Hormone +17

The Script Concordance Test: A Tool to Assess the Reflective Clinician

Bernard Charlin, Louise Roy, Carlos Brailovsky et al. · Teaching and Learning in Medicine · 2000 · 352 citations

Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.

Jean‐Hugues Brossard, Myriam Cloutier, Louise Roy et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 270 citations · Full text

Urology, Renal Function, Molecular Form +15

Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs

Alice Dragomir, Robert Côté, Louise Roy et al. · Medical Care · 2010 · 220 citations